Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ependymoma × cediranib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Fallopian Tube Neoplasms 6 Ovarian Neoplasms 5 Colorectal Neoplasms 5 Prostatic Neoplasms 4 Neoplasms 4 Glioblastoma 4 Carcinoma, Renal Cell 3 Triple Negative Breast Neoplasms 2 Solitary Fibrous Tumor, Pleural 2 Sarcoma, Alveolar Soft Part 2 Sarcoma 2 Mesothelioma, Malignant 2 Lung Neoplasms 2 Gliosarcoma 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Uveal Melanoma 1 Thyroid cancer, Hurthle cell 1 Thyroid Cancer, Papillary 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neoplasm Metastasis 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Temozolomide 7 Magnetic Resonance Spectroscopy 5 Bevacizumab 5 X-Rays 4 Phantoms, Imaging 4 Specimen Handling 3 Nuclear Medicine Department, Hospital 3 Carboplatin 3 Lapatinib 2 Everolimus 2 Etoposide 2 Erlotinib Hydrochloride 2 Biopsy 2 veliparib 1 ulixertinib 1 tipifarnib 1 tazemetostat 1 selpercatinib 1 pomalidomide 1 poly ICLC 1 picropodophyllin 1 palbociclib 1 olaparib 1 marizomib 1 larotrectinib 1 imetelstat 1 erdafitinib 1 dinutuximab 1 bempegaldesleukin 1 antineoplaston AS 2-1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡